TOC Co., Ltd. (TYO:8841)
733.00
-1.00 (-0.14%)
Aug 1, 2025, 3:30 PM JST
Verve Therapeutics Revenue
In the fiscal year ending March 31, 2025, TOC Co., Ltd. had annual revenue of 13.15B JPY, down -4.10%. TOC Co., Ltd. had revenue of 3.50B in the quarter ending March 31, 2025, with 2.64% growth.
Revenue
13.15B
Revenue Growth
-4.10%
P/S Ratio
4.92
Revenue / Employee
90.70M
Employees
145
Market Cap
64.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 13.15B | -563.00M | -4.10% |
Mar 31, 2024 | 13.72B | -1.97B | -12.57% |
Mar 31, 2023 | 15.69B | -651.00M | -3.98% |
Mar 31, 2022 | 16.34B | 250.00M | 1.55% |
Mar 31, 2021 | 16.09B | -2.29B | -12.47% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Mitsui Fudosan | 2,625.36B |
Mitsubishi Estate | 1,579.81B |
Daiwa House Industry | 5,434.82B |
Sumitomo Realty & Development | 1,014.24B |
Nippon Building Fund | 101.03B |
Hulic | 686.84B |
Daito Trust Construction | 1,842.36B |
Japan Real Estate Investment | 85.82B |